Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,047,617
-
Share change
-
+1,443,503
-
Total reported value
-
$51,110,000
-
Price per share
-
$16.77
-
Number of holders
-
28
-
Value change
-
+$24,210,000
-
Number of buys
-
25
Institutional Holders of EIGER BIOPHARMACEUTICALS INC - COM (EIGR) as of Q1 2016
As of 31 Mar 2016,
EIGER BIOPHARMACEUTICALS INC - COM (EIGR) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,047,617 shares.
The largest 10 holders included
Vivo Capital, LLC, RA CAPITAL MANAGEMENT, LLC, SABBY MANAGEMENT, LLC, EcoR1 Capital, LLC, SPHERA FUNDS MANAGEMENT LTD., Lombard Odier Asset Management (USA) Corp, PERCEPTIVE ADVISORS LLC, Boxer Capital, LLC, Monashee Investment Management LLC, and VANGUARD GROUP INC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.